Ceftriaxone vs ampicillin coverage

    • [DOC File]Fever Pre-Topic Questions

      https://info.5y1.org/ceftriaxone-vs-ampicillin-coverage_1_fc4f86.html

      Because of her young age and potential hyperbilirubinemia caused by displacement of bilirubin from albumin by ceftriaxone, ampicillin and cefotaxime were chosen as first-line antibiotics. 2. You are called by the Emergency Department to admit an ill-appearing 1 year-old boy with fevers, anemia, thrombocytopenia, and hypofibrinogenemia.

      ampicillin and ceftriaxone compatibility


    • [DOC File]www.joshcorwin.com

      https://info.5y1.org/ceftriaxone-vs-ampicillin-coverage_1_f83f7f.html

      – GASTROENTEROLOGY. Course Coordinator: SECTION DESCRIPTION. In this section, the student is provided the fundamental concepts necessary to …

      ampicillin and ceftriaxone synergy


    • [DOCX File]SOHM LIBRARY - SOHM Library

      https://info.5y1.org/ceftriaxone-vs-ampicillin-coverage_1_555465.html

      coverage with ampicillin or penicillin G for children hospitalized with uncomplicated CAP. ... General Rule: Empiric therapy with a third-generation parenteral cephalosporin (e.g. ceftriaxone or cefotaxime) should be prescribed for hospitalized children who are not fully immunized, in regions where local epidemiology of invasive pneumococcal ...

      unasyn vs ceftriaxone coverage


    • [DOC File]General Outline for Antibiotics (a good study guide)

      https://info.5y1.org/ceftriaxone-vs-ampicillin-coverage_1_a4296f.html

      A. spectrum of coverage . 1. broad (both G+ and G-, but some fluoroquinolones have better coverage against G+ than others) 2. works well against intracellular pathogens. 3. newer fluoroquinolones work against anaerobes. B. mechanism of action. 1. targets are DNA gyrase (for G-) and topoisomerase IV (for G+) 2.

      cefepime vs zosyn coverage


    • [DOC File]Pharmacology

      https://info.5y1.org/ceftriaxone-vs-ampicillin-coverage_1_d9e275.html

      A. ampicillin (oral, IV, IM) B. amoxicillin (oral) ... --lacks ceftriaxone’s extended coverage against gram negative enterics—no serodia, enterobacter, etc. 2. cefpodoxime (Vantin)—same as cefixime, plus some coverage against S. pneumo and S. aureus (minor skin infxs)

      unasyn vs cefepime


    • [DOC File]Staphylococcus

      https://info.5y1.org/ceftriaxone-vs-ampicillin-coverage_1_6f3f8b.html

      Pneumonia: ceftriaxone or cefotaxime or cefepime / levofloxacin or moxifloxicin / vanc +/- rifampin . Note: macrolides actually are active against pneumococcus, the issues is that they may be more active in tissue, and not provide adequate blood/CSF coverage (given high propensity of Pneumococcus toward bacteremia)

      unasyn vs augmentin coverage


    • [DOC File]Drug - University of Washington

      https://info.5y1.org/ceftriaxone-vs-ampicillin-coverage_1_e4e74b.html

      The sulbactam improves the S. aureus and anaerobic coverage of ampicillin, but only modestly improves G- coverage. DOC for which diseases Intra-abdominal infections. With advanced macrolide (azithromycin) for CAP treated on inpatient basis, non ICU (especially if aspiration pneumonia is a concern) Absorption, distribution, metabolism, excretion ...

      ceftazidime vs ceftriaxone coverage


    • [DOC File]National PBM Monograph Template Rev20091005

      https://info.5y1.org/ceftriaxone-vs-ampicillin-coverage_1_ba7dc7.html

      Community-Acquired Bacterial Pneumonia: Parenteral agents on VANF include ampicillin, ampicillin-sulbactam, azithromycin (used in combination with beta-lactam), ceftriaxone, cefotaxime, and moxifloxacin. Dosage and Administration1-3. The recommended adult dosage is 600 mg administered intravenous infusion every 12 hours over 1 hour.

      cefepime vs ceftriaxone coverage chart


    • [DOCX File]AHRQ Safety Program for Improving Antibiotic Use

      https://info.5y1.org/ceftriaxone-vs-ampicillin-coverage_1_bf75a1.html

      There are several options for empiric therapy but for most patients, ampicillin-sulbactam and azithromycin or ceftriaxone and azithromycin are reasonable choices. Both of these agents provide similar coverage for common bacteria causes of CAP but ceftriaxone has a stronger association with the development of

      ampicillin and ceftriaxone compatibility


Nearby & related entries: